Conway Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18M | Sell |
29,645
-1,725
| -5% | -$185K | 1.42% | 15 |
|
|
2025
Q1 | $3.16M | Sell |
31,370
-555
| -2% | -$56K | 1.58% | 15 |
|
|
2024
Q4 | $2.85M | Hold |
31,925
| – | – | 1.26% | 16 |
|
|
2024
Q3 | $2.68M | Hold |
31,925
| – | – | 1.3% | 17 |
|
|
2024
Q2 | $2.46M | Hold |
31,925
| – | – | 1.24% | 15 |
|
|
2024
Q1 | $2.19M | Hold |
31,925
| – | – | 1.22% | 15 |
|
|
2023
Q4 | $1.85M | Sell |
31,925
-2,090
| -6% | -$121K | 1.19% | 16 |
|
|
2023
Q3 | $1.8M | Sell |
34,015
-3,375
| -9% | -$178K | 1.31% | 15 |
|
|
2023
Q2 | $2.02M | Sell |
37,390
-2,550
| -6% | -$138K | 1.42% | 14 |
|
|
2023
Q1 | $2M | Sell |
39,940
-2,650
| -6% | -$133K | 1.64% | 14 |
|
|
2022
Q4 | $1.97M | Buy |
42,590
+7,250
| +21% | +$335K | 1.99% | 13 |
|
|
2022
Q3 | $1.37M | Sell |
35,340
-135
| -0.4% | -$5.23K | 1.22% | 17 |
|
|
2022
Q2 | $1.32M | Sell |
35,475
-550
| -2% | -$20.5K | 1.18% | 19 |
|
|
2022
Q1 | $1.6M | Buy |
36,025
+4,875
| +16% | +$216K | 1.02% | 18 |
|
|
2021
Q4 | $1.32M | Buy |
31,150
+2,000
| +7% | +$85K | 0.78% | 23 |
|
|
2021
Q3 | $1.26M | Hold |
29,150
| – | – | 0.86% | 24 |
|
|
2021
Q2 | $1.25M | Hold |
29,150
| – | – | 0.85% | 24 |
|
|
2021
Q1 | $1.13M | Sell |
29,150
-1,800
| -6% | -$69.6K | 0.84% | 25 |
|
|
2020
Q4 | $1.11M | Buy |
+30,950
| New | +$1.11M | 0.81% | 25 |
|